جستجوی استاد راهنمای دانشگاهی

Xin Guoمشاهده پروفایل

استاد

• Mathematical Finance
• Financial Engineering
• FinTech
• +۷ مورد دیگر

Xin Guo is Professor and Department Chair of Industrial Engineering and Operations Research (IEOR) at UC Berkeley's College of Engineering, holding the Coleman Fung Chair in Financial Modeling. Her research bridges mathematical finance, stochastic control, and machine learning with applications in risk analytics and quantitative trading. Education: Ph.D. in Mathematics, Rutgers University (1999) Research Interests: Professor Guo's work centers on mathematical finance , stochastic games , and reinforcement learning . She develops theoretical frameworks for α-potential games and mean-field systems while applying signature methods and GANs to financial data. Her research addresses critical problems in portfolio optimization, fraud detection (e.g., Medicare analytics), and market forecasting, emphasizing the intersection of stochastic control with machine learning for real-world decision-making under uncertainty. Publication Trends: Recent work (2023-2025) shows increasing focus on multi-agent reinforcement learning through mean-field game theory, with applications spanning finance (corporate bonds, trading), healthcare (fraud detection), and transportation (rate forecasting). Key innovations include BSDE approaches for stochastic games, signature-based time series analysis, and theoretical guarantees for GAN training dynamics. Scientific Awards: Holds the prestigious Coleman Fung Chair in Financial Modeling, reflecting significant contributions to quantitative finance research. Advising and Grants: As IEOR Department Chair, Professor Guo mentors graduate students in stochastic modeling and financial engineering. Her research is supported by the Coleman Fung Endowment Fund, with collaborations spanning finance, healthcare, and transportation sectors through industry partnerships. Labs and Teams: Leads the Risk Analytics & Data Analysis Research (RADAResearch) Lab ( https://risklab.ieor.berkeley.edu/ ), which develops cutting-edge methodologies for risk assessment, data-driven decision-making, and game-theoretic solutions to complex systems. The lab fosters interdisciplinary work connecting mathematical theory with practical applications in FinTech and beyond.

Robert Rohlingمشاهده پروفایل

استاد

• Biomedical Engineering
• Medical Imaging
• Medical Information Systems
• +۳ مورد دیگر

Robert Rohling is a Professor at the University of British Columbia's Faculty of Applied Science, affiliated with the Department of Mechanical Engineering and holding a joint appointment with the Department of Electrical and Computer Engineering. As Director of the Institute of Computing, Information and Cognitive Systems (ICICS), his research focuses on biomedical engineering, medical imaging, robotics, and computational methods. B.A.Sc. (UBC) M.Eng. (McGill) Ph.D. (Cambridge) Rohling's work spans three primary research areas: medical imaging (3D ultrasound, spatial compounding, elasticity reconstruction), medical information systems (radiologist navigation tools for large image datasets), and robotic calibration for surgical applications. His multidisciplinary approach integrates mechanical and electrical engineering principles with clinical needs. Rohling's publications (2020-2022) reveal trends in advanced ultrasound techniques (e.g., shear wave vibro-elastography), AI-driven image processing (cycleGAN translation), and computational optimization for diagnostic accuracy. Keywords across his work include Medical Imaging, Biomedical Engineering, Robotics, and Computational Modeling. As director of the Robotics and Control Laboratory , Rohling leads interdisciplinary collaborations with industry and clinical partners to address practical challenges in medical diagnostics and surgical robotics. His research emphasizes translating engineering innovations into clinical practice.

Hang Luمشاهده پروفایل

استاد

• Microfluidics
• Systems Biology
• Neuroscience
• +۶ مورد دیگر

Hang Lu is a Professor and holds the Cecil J. "Pete" Silas Chair of Chemical & Biomolecular Engineering at the Georgia Institute of Technology. Dr. Lu also holds a Love Family Professorship and leads the Lµ Fluidics Group, which focuses on engineering microfluidic systems and machine learning tools to address complex questions in neuroscience, developmental biology, and cell biology that are difficult to address with conventional techniques. Dr. Lu's research lies at the intersection of engineering and biology, with primary interests including: Microfluidic systems for high-throughput screens and image-based genetics and genomics Systems biology: large-scale experimentation and data mining Microtechnologies for optical stimulation and optical recording Big data, machine vision, and automation Developmental neurobiology, behavioral neurobiology, and systems neuroscience Cancer biology, immunology, embryonic development, and stem cells Her laboratory engineers microfluidic devices and BioMEMS to study neuroscience, genetics, cancer biology, and biotechnology. These miniaturized Lab-on-a-chip tools operate at scales comparable to biological systems, leveraging unique micro and nano-scale phenomena to gather large-scale quantitative data about complex biological systems. Current projects include Microfluidics for Life Sciences, Optical Neuron Recordings and Manipulations, Machine Learning Tools for Neuroscience, Measuring and Modeling Behavior, and High-throughput, High-content Cell-based Assays. Analysis of Dr. Lu's recent publications (2024-2025) reveals a strong trend toward integrating microfluidics with advanced computational methods: Development of deep learning frameworks for biological image analysis Advanced neuron tracking and functional imaging techniques Non-invasive characterization of 3D organoid cultures Sophisticated neuromechanical modeling of locomotion Microfluidic temperature control systems for in vivo studies Label-free imaging pipelines for neural development Dr. Lu's significant professional honors include: Cecil J. "Pete" Silas Chair of Chemical & Biomolecular Engineering Love Family Professorship The Lµ Fluidics Group actively mentors students and postdocs, currently accepting new postdoctoral researchers. The lab receives substantial funding for interdisciplinary projects at the engineering-biology interface, with research implications spanning fundamental biological understanding to therapeutic development. The group operates within Georgia Tech's School of Chemical & Biomolecular Engineering, with specialized facilities for microfluidic device fabrication, biological experimentation, and advanced imaging, maintaining strong collaborative ties across engineering, neuroscience, and biological disciplines.

Alexis Battleمشاهده پروفایل

دانشیار

• Genomics
• Machine Learning
• Computational Biology
• +۳ مورد دیگر

Alexis Battle is an Associate Professor at Johns Hopkins University with appointments in Biomedical Engineering , Computer Science , and Genetic Medicine (secondary). She directs the Malone Center for Engineering in Healthcare and serves as Deputy Director of the Data Science and AI Institute . Educated at Stanford University (PhD in Computer Science, 2013), Battle transitioned to academia after leadership roles at Google. Research Focus: Battle’s work bridges genomics and machine learning , emphasizing the impact of genetic variation on human health. Her lab develops tools like Watershed to predict functional effects of rare variants, aiming to enhance rare disease diagnosis. Key themes include non-coding DNA analysis , personalized genomics , and systems biology , with applications in cardiovascular disease and neurodegenerative disorders . Publications & Awards: Over 60 peer-reviewed articles in journals like Nature , Science , and Genome Biology , with recent emphasis on single-cell transcriptomics , multiomics integration , and telomere biology . Recipient of the President’s Frontier Award (2022), Microsoft Investigator Fellowship (2019), and Searle Scholar (2016). Scientific Awards: 2022 President’s Frontier Award 2019 Microsoft Investigator Fellowship 2019 Johns Hopkins Discovery Award 2017 Johns Hopkins Catalyst Award 2016 Searle Scholar Advising & Funding: Mentors 11 PhD students, 3 undergraduates, and postdoctoral fellows. Her research is funded by NIH, Searle Scholars, and institutional grants. The Battle Lab collaborates on projects like the GTEx Consortium , focusing on gene regulation and clinical genomics .

Mengliang Zhangمشاهده پروفایل

دانشیار

• Forensic Chemistry
• Food and Agricultural Chemistry
• Metabolomics
• +۱۲ مورد دیگر

Mengliang Zhang is an Associate Professor in the Department of Chemistry and Biochemistry at Ohio University, College of Arts and Sciences. He leads an interdisciplinary research group focused on mass spectrometry and chemometrics, with applications in forensic, food, agricultural, environmental, and material sciences. His lab develops innovative analytical strategies for detecting toxicants, characterizing nanomaterials, and profiling metabolites in botanicals and food systems. Ph.D., Chemistry, Ohio University, 2015 Dr. Zhang’s research integrates instrumentation, chemometrics, and computational tools to address complex analytical challenges. His group works on forensic fiber and ignitable liquid analysis, plant metabolomics, nanomaterial surface chemistry, and environmental toxicant monitoring. His work is highly interdisciplinary, bridging chemistry, data science, and real-world applications in forensics and public health. His recent publications demonstrate a strong trend in advancing ambient ionization mass spectrometry (especially DART-MS), chemometric modeling, and metabolite profiling across diverse matrices—from fire debris to broccoli microgreens. His work increasingly emphasizes automation, quantitation, and database development for botanical phytochemicals. Scientific honors include the MTSU Distinguished Research Award (Early Career), and his students have received prestigious awards such as the Goldwater Scholarship and multiple URECA recognitions. He is actively supported by federal grants from NSF, USDA, DOE, DOJ (NIJ), and FEMA. Dr. Zhang mentors a vibrant research team of graduate and undergraduate students, guiding them in publishing high-impact research and presenting at national conferences like ASMS, Pittcon, and AAFS. He has organized sessions at SciX and served on editorial boards of Journal of Forensic Sciences and Journal of AOAC INTERNATIONAL . His lab recently relocated to Ohio University in August 2024, equipped with advanced instrumentation including UHPLC-QTOF-MS and DART-MS systems.

Dewey G. McCaffertyمشاهده پروفایل

استاد

• Chemical Biology
• Chromatin Modification
• Enzymology
• +۳ مورد دیگر

Dewey G. McCafferty is Professor of Chemistry at Duke University with appointments in Biochemistry and the Duke Cancer Institute. His research focuses on chemical biology of chromatin-modifying enzymes and ubiquitin signaling pathways relevant to neurodegeneration and infection. Notable work includes discovering the lasso peptide antibiotic Arcumycin, characterizing the Nedd4 ubiquitin ligase in Parkinson's disease models, and developing chemoproteomic approaches for target identification. Key contributions include elucidation of the futalosine pathway in Chlamydia infections, mechanisms of CPAF protease in bacterial pathogenesis, and engineering of histone demethylase enzymes. McCafferty received the Eli Lilly Award in Biological Chemistry (2005) and directs NIH-funded projects on ubiquitin ligases in neurodegeneration.

• Machine Learning
• Physics-Informed Machine Learning
• Interpretable Machine Learning
• +۳ مورد دیگر

Yan Liu is a full professor in the Thomas Lord Department of Computer Science at the University of Southern California (USC), serving as Director of the USC Machine Learning Center within the Viterbi School of Engineering. He holds courtesy appointments in the Ming Hsieh Department of Electrical Engineering and the Quantitative and Computational Biology Department. Before joining USC in 2010, he was a research staff member at IBM's T.J. Watson Research Center. He earned his M.S. and Ph.D. from Carnegie Mellon University. His research focuses on machine learning for time series, physics-informed AI, and interpretable models, with applications in healthcare, sustainability, and social media. Notable projects include developing AI for surgical training, analyzing misinformation on social platforms, and predicting cancer treatment outcomes. He has held leadership roles in top conferences like ICLR and ACM KDD, and serves as Associate Editor-in-Chief of TPAMI and Board Member of ICLR. Education: Ph.D., Carnegie Mellon University Affiliations: USC Machine Learning Center, Viterbi School of Engineering Service: General Chair (ICLR 2023, ACM KDD 2020), Program Chair roles across multiple conferences His lab, the Melady Group, emphasizes foundational ML advancements and interdisciplinary applications. Recent work includes physics-aware neural networks and time-series foundation models.

Hassan Rivazمشاهده پروفایل

استاد

• Medical image analysis
• Deep learning
• Machine learning
• +۵ مورد دیگر

Professor Hassan Rivaz is a Full Professor and Concordia University Research Chair in Medical Imaging with Deep Learning at Concordia University's Gina Cody School of Engineering and Computer Science. He holds appointments in the Department of Electrical and Computer Engineering and is cross-appointed to the Department of Computer Science & Software Engineering. Dr. Rivaz serves as the Founding Director of the IMPACT Lab and actively supervises PhD students in Electrical and Computer Engineering and Computer Science programs. Dr. Rivaz received his PhD from Johns Hopkins University in 2011, Master's degree from the University of British Columbia, and Bachelor's degree from Sharif University, followed by postdoctoral training at McGill University. His academic journey includes prestigious awards such as the NSERC Post-Doctoral Fellowship and Jeanne Timmins Costello Post-Doctoral Award. His research focuses on advancing medical image analysis through deep learning techniques, particularly in ultrasound imaging applications. Dr. Rivaz has made significant contributions to quantitative ultrasound, cancer detection, lymphedema assessment, and ultrasound elastography. His work bridges theoretical algorithm development with practical clinical applications, addressing challenges in medical image denoising, segmentation, registration, and tissue characterization. The IMPACT Lab under his direction develops innovative solutions for medical imaging problems with direct clinical relevance. Analysis of his recent publications reveals a strong emphasis on deep learning applications for ultrasound image processing, with particular focus on denoising techniques, elastography improvements, and segmentation algorithms. His work consistently addresses the challenge of working with real clinical data rather than simulated environments, contributing to more practical medical imaging solutions. Dr. Rivaz has received numerous prestigious awards including: Concordia University Research Chair in Medical Imaging with Deep Learning (2023–2028) QBIN/RBIQ Rising Star in Bio-Imaging in Quebec (2022) Concordia University Research Chair in Medical Image Analysis (2018-2023) Petro-Canada Young Innovator Award (2016–2018) He actively mentors graduate students, with many recipients of competitive scholarships including NSERC CGS, FRQNT, and FRQS awards. Dr. Rivaz serves on editorial boards for top journals including IEEE Transactions on Medical Imaging (since 2017), Medical Image Analysis (since 2025), and IEEE Transactions on Ultrasonics, Ferroelectrics and Frequency Control (since 2018). He has organized major conferences including IEEE EMBC 2020, ISBI 2021, and IEEE IUS 2023, and served as Area Chair for MICCAI from 2017 to 2024. As Founding Director of the IMPACT Lab, Dr. Rivaz leads a multidisciplinary research team focused on innovative medical imaging solutions. The lab maintains strong collaborations with hospitals and research institutions to translate imaging technologies into clinical practice. Current projects include developing AI-powered ultrasound analysis tools, quantitative imaging biomarkers for cancer diagnosis, and advanced techniques for ultrasound elastography with applications in tissue characterization and disease detection.

Jeremy Dahlمشاهده پروفایل

استاد

• Medical Ultrasound Imaging
• Ultrasonic Beamforming
• Image Reconstruction
• +۷ مورد دیگر

Jeremy Dahl is a Professor of Radiology (Pediatric Radiology) at Stanford University School of Medicine. He directs the Ultrasound Imaging & Instrumentation Lab and serves as Director of Research Academic Affairs in the Department of Radiology since 2020. He holds multiple affiliations across Stanford including Bio-X, the Cardiovascular Institute, Wu Tsai Human Performance Alliance, Maternal & Child Health Research Institute, Stanford Cancer Institute, and Wu Tsai Neurosciences Institute. Dr. Dahl received his B.S. in Electrical Engineering from the University of Cincinnati (1999) and Ph.D. in Biomedical Engineering from Duke University (2004). His research focuses on developing ultrasonic beamforming and image reconstruction methods for diagnostic imaging applications, particularly techniques that generate high-quality images in difficult-to-image patients. His laboratory specializes in B-mode and Doppler imaging techniques that utilize additional information from ultrasonic wavefields to improve image quality and develop real-time imaging systems for clinical applications including cardiac, liver, and fetal imaging. Dr. Dahl's research has led to significant advancements in ultrasound molecular imaging platforms, sound speed estimation, aberration correction, and reverberation noise suppression. His work often bridges engineering innovation with clinical applications for cancer detection and other diseases. His recent publications demonstrate strong focus on machine learning applications in ultrasound, distributed aberration correction, and molecular imaging techniques. Fellow, American Institute of Ultrasound in Medicine (2021) Senior Member, Institute of Electrical and Electronics Engineers (2020) Distinguished Investigator Award, The Academy for Radiology & Biomedical Imaging Research (2018) Outstanding Paper Award, IEEE Ultrasonics, Ferroelectrics, and Frequency Control Society (2011) Dr. Dahl serves in editorial roles for major journals including IEEE Transactions on Medical Imaging (2017-2024) and IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control (2013-Present). His laboratory has successfully translated numerous innovations into clinical applications, with multiple patents including recent developments in pulsed focused ultrasound therapy and speed of sound quantification.

Massimo Mischiمشاهده پروفایل

استاد

• Biomedical Signal Processing
• Diagnostic Imaging
• Ultrasound Technology
• +۴ مورد دیگر

Massimo Mischi is a Full Professor at the Faculty of Electrical Engineering of the Eindhoven University of Technology (TU/e) and chairs the Signal Processing Systems (SPS) Division , the largest division at TU/e with over 250 researchers. He founded the Biomedical Diagnostics (BM/d) Lab in 2012, which now includes 180 researchers and clinical/industrial advisors, focusing on biomedical signal processing for diagnostics and monitoring.

John H. Shawمشاهده پروفایل

استاد

• Structural Geology
• Seismology
• Tectonics
• +۳ مورد دیگر

John H. Shaw is the Harry C. Dudley Professor of Structural and Economic Geology and Professor of Environmental Science & Engineering at Harvard University's School of Engineering and Applied Sciences (SEAS). He specializes in structural geology, earthquake hazards, and geomechanics, with a focus on thrust fault systems, fault-related folding, and seismic risk assessment in regions like California and China. His research integrates field observations, 3D modeling, and geomechanical simulations to understand fault dynamics and their implications for societal safety. Shaw's work emphasizes quantitative analysis of fault geometry, slip rates, and rupture processes. Key projects include modeling ground deformation during earthquakes, assessing seismic hazards in fold-thrust belts, and investigating reservoir-induced seismicity. He leads the Structural Geology & Earth Resources Group and contributes to collaborative initiatives like the Southern California Earthquake Center (SCEC). His articles highlight advancements in fault system modeling, including 3D structural reconstructions, distinct element method applications, and coupling geomechanical models with fluid flow simulations. Recent studies focus on the Wilmington blind-thrust fault beneath Los Angeles, the Ventura fault system, and tectonic evolution of the Canadian Rockies and Qaidam Basin. Shaw's research also addresses interdisciplinary challenges such as stochastic velocity modeling for earthquake ground motion prediction and developing open-source tools like the SCEC Unified Community Velocity Model (UCVM). His work bridges fundamental structural geology with applied seismic hazard mitigation strategies.

• Environmental Engineering
• Hydrology
• Hydraulics
• +۱۲ مورد دیگر

Joel S. Hayworth is an Associate Professor in the Department of Civil Engineering at Auburn University's College of Engineering. His research focuses on environmental and ecosystem restoration, particularly in estuarine, terrestrial, and freshwater systems. He leads the Estuarine Environments Research Program (EERP), which investigates the fate of endocrine-disrupting chemicals (EDCs), PFAS, and oil spill residues in coastal environments. Dr. Hayworth's educational background includes a PhD in Civil Engineering (Hydrology/Hydraulics) from Auburn University, an MS in Hydrology from the University of Nevada, Las Vegas via the Desert Research Institute, and a BS in Geophysics from the University of California, Santa Barbara. He previously worked at the Tennessee Valley Authority Engineering Laboratory and the U.S. Air Force Research Laboratory, and founded Hayworth Engineering Science in 1999 before returning to academia in 2010. His research interests span environmental engineering, hydrology, hydraulics, estuarine science, pollutant fate and transport, and chemical fingerprinting. He has developed advanced analytical methods for detecting EDCs and PFAS in water, sediment, and biota. His work integrates field studies, laboratory experiments, and environmental modeling to understand complex hydrologic, geologic, chemical, and biological processes in human-impacted ecosystems. The 15 most recent articles highlight a strong trend in environmental contaminant analysis, particularly focusing on PFAS, oil spill residues, and endocrine disruptors. His research combines analytical chemistry with environmental modeling and field monitoring, often in collaboration with interdisciplinary teams. Key themes include the development of UHPLC-MS/MS and GC-MS/MS methods, fate and transport modeling of pollutants, and ecological risk assessment in estuarine systems. Dr. Hayworth's scientific contributions are supported by funding from agencies such as the Gulf Coast Ecosystem Restoration Council (RESTORE Council). His work has led to significant publications in journals like Science of the Total Environment , Marine Pollution Bulletin , and Water . He actively mentors students and collaborates with researchers like T.P. Clement, G.F. John, and V. Mulabagal. His projects, such as the restoration assessment of Cotton Bayou and Terry Cove, demonstrate applied science for environmental problem-solving. He has developed state-of-the-art analytical laboratories and partnered with coastal communities for long-term monitoring. His laboratory, the Estuarine Environments Research Program (EERP), conducts multi-year studies on endocrine disruptors in estuaries, develops innovative sampling and analysis methods, and trains the next generation of environmental engineers and scientists. The team works across disciplines to address complex environmental challenges in the Gulf Coast region.

Omer Bayraktarمشاهده پروفایل

پژوهشگر

• Neural Diversity
• Spatial Transcriptomics
• Glia Biology
• +۳ مورد دیگر

Omer Bayraktar is a Group Leader at the Wellcome Sanger Institute , leading research in the Cellular Genomics Programme. His work focuses on decoding human brain cellular diversity using spatial transcriptomics , imaging , and functional screening to study neural complexity in health and disease. Bayraktar's educational background includes a PhD from HHMI under Chris Doe, investigating neural diversity development in Drosophila , followed by postdoctoral work at University of California, San Francisco and University of Cambridge as a Life Sciences Research Foundation Fellow. He developed a spatial transcriptomic pipeline during his postdoc to analyze astrocyte heterogeneity in the cerebral cortex. His research explores neural cell type mapping , glial-neuronal interactions , and cellular pathways in neurodevelopmental disorders . Recent publications emphasize 3D tissue mapping , multi-omic integration , and computational tools like Cell2fate and WebAtlas. His work bridges neurogenetics and computational biology to advance understanding of human tissue ecosystems. Bayraktar's lab collaborates with the Human Cell Atlas initiative and develops technologies such as automated histology pipelines and highly-multiplexed smFISH for molecular cell typing. His team also investigates glia-based therapies and astrocyte functional heterogeneity in neurodevelopmental contexts. Key scientific contributions include: Discovering astrocyte layer patterns independent of neuronal laminae Developing cell2location for spatial cell mapping Characterizing Drosophila neural stem cell models with human relevance Notable awards include the Life Sciences Research Foundation Fellowship during his postdoctoral training. His current group includes a PhD student , Senior Data Scientists , and Bioinformaticians .

• Inverse problems and reconstruction
• Neuroimaging
• Quantitative MRI
• +۱ مورد دیگر

Daan Christiaens is a tenure track lecturer at KU Leuven's Faculty of Medicine and Faculty of Engineering Sciences. He is affiliated with the Department of Electrical Engineering (ESAT) and Department of Imaging & Pathology, serving as a member of the Medical Imaging Division and the KU Leuven Brain Institute (LBI). His academic responsibilities include membership in the Faculty Councils of Engineering Sciences and Medicine. His research focuses on: Inverse problems in medical imaging reconstruction Neuroimaging techniques for brain analysis Advanced quantitative MRI methodologies Diffusion-weighted imaging for microstructural assessment Dr. Christiaens' recent publications (2023-2025) demonstrate a consistent focus on diffusion MRI innovations, including novel reconstruction algorithms, neonatal brain development mapping, and clinical applications for neurodegenerative disorders. Key technical themes include motion correction, multi-shell modeling, and AI-enhanced image processing, while clinical applications span Alzheimer's disease, cerebral palsy, and autism research. He leads significant research projects including: MRI reconstruction with dynamic field monitoring (2024-2028) Compressed sensing for microstructure imaging (2022-2026) Neonatal diffusion MRI network connectivity analysis (2024-2028) As a core developer of the MRtrix3 software framework for medical image processing, he contributes to essential tools in neuroimaging research.

Liang Zhaoمشاهده پروفایل

استاد

• Pharmacometrics
• Drug Delivery Modeling
• Artificial Intelligence in Drug Development
• +۵ مورد دیگر

Liang Zhao, PhD, MAS, MBA, is a Professor in the Department of Bioengineering and Therapeutic Sciences within the Schools of Pharmacy and Medicine at the University of California, San Francisco (UCSF). Prior to joining UCSF, he served as director of the Division of Quantitative Methods and Modeling (DQMM) in the Office of Research and Standards in the Office of Generic Drugs in the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) from 2015 to 2024. His professional career spans over 19 years with experience at Pharsight, Bristol Myers Squibb (BMS), MedImmune, and the FDA. Dr. Zhao's research focuses on pharmacometrics, drug delivery modeling, and artificial intelligence-based tools that impact drug development and regulatory decision-making. His work encompasses mechanistic models for brain drug delivery, regulatory science modeling and simulation, AI-driven drug discovery and development, drug interactions, biological availability, generic drugs, clinical pharmacology, therapeutic equivalency, computer simulation, and FDA regulatory processes. He has pioneered innovative approaches including model master files for model sharing and model-integrated evidence for generic product development and approval. His research integrates machine learning tools into pharmacometrics to advance drug delivery and bioequivalence assessment methodologies. Dr. Zhao has published over 120 articles and book chapters in prestigious journals. His recent publications demonstrate strong focus on applying advanced modeling techniques, machine learning algorithms, and pharmacometric approaches to solve complex problems in drug development and regulatory science. His work shows consistent innovation in developing quantitative methods to enhance bioequivalence assessment, improve drug product characterization, and support regulatory decision-making for generic drugs. FDA Group Recognition Award, FDA, 2024 Gary Neil Prize for Innovation in Drug Development, American Society for Clinical Pharmacology & Therapeutics (ASCPT), 2023 Commissioner's Special Citation, FDA, 2021 Humanitarian Award, Victims' Rights Foundation, 2020 30+ FDA CDER team and Individual Awards, CDER, FDA, 2011 Academic Award for Executive MBA Class 2009, Judge Business School, University of Cambridge, 2011 Dr. Zhao leads the Zhao Lab at UCSF, which advances drug development and regulatory science through cutting-edge research in pharmacometrics, drug delivery modeling, and artificial intelligence. His work bridges academic research with regulatory applications, demonstrating leadership in translating scientific innovations into practical regulatory frameworks. His experience across industry, regulatory agencies, and academia provides a unique perspective on drug development challenges and opportunities.